Prot #HCRN LUN18-335/NU MDA20L01: An Open-Label Randomized Phase II Study of Combining Osimertinib with and without Ramucirumab in TKI-naïve EGFR-mutant Locally Advanced or Metastatic NSCLC
- Patel, Jyoti D (PD/PI)
Project: Research project
Project: Research project